NextCure Valuation
| NXTC Stock | USD 12.72 0.28 2.15% |
At this time, the firm appears to be undervalued. NextCure secures a last-minute Real Value of $14.1 per share. The latest price of the firm is $12.72. Our model forecasts the value of NextCure from analyzing the firm fundamentals such as Shares Owned By Insiders of 20.16 %, return on equity of -1.17, and Current Valuation of 19.72 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that NextCure's price fluctuation is somewhat reliable at this time. Calculation of the real value of NextCure is based on 3 months time horizon. Increasing NextCure's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since NextCure is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NextCure Stock. However, NextCure's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 12.72 | Real 14.1 | Hype 12.72 | Naive 11.68 |
The real value of NextCure Stock, also known as its intrinsic value, is the underlying worth of NextCure Company, which is reflected in its stock price. It is based on NextCure's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of NextCure's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of NextCure helps investors to forecast how NextCure stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NextCure more accurately as focusing exclusively on NextCure's fundamentals will not take into account other important factors: About NextCure Valuation
The stock valuation mechanism determines NextCure's current worth on a weekly basis. Our valuation model uses a comparative analysis of NextCure. We calculate exposure to NextCure's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of NextCure's related companies.NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland. Nextcure operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people.
Complementary Tools for NextCure Stock analysis
When running NextCure's price analysis, check to measure NextCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextCure is operating at the current time. Most of NextCure's value examination focuses on studying past and present price action to predict the probability of NextCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextCure's price. Additionally, you may evaluate how the addition of NextCure to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |